SleepWell Trade

Trend-Following Backtester · Guide · backtest 한국어

equity · US

Iovance Biotherapeutics, Inc. backtest

10 trend-following strategies were compared on the full daily history of Iovance Biotherapeutics, Inc.. 6 beat buy-and-hold CAGR; ADX / DI 방향성 ranks first by Sharpe, matching the main backtester. The return/drawdown alternative is 볼린저 밴드 돌파 (CAGR 7.1%, MDD -40.3%).

Data 2010-10-15 ~ 2026-08-31daily bars 3,992 (15.9 years)Costs 0.5%Venue XNASMonthly snapshot 2026-08-31

Results by strategy

6 of 10 beat buy and hold (CAGR -15.1%, drawdown -99.4%).

Sharpe leader (same as main): ADX / DI 방향성 — CAGR 11.3%, MDD -77.1%, Sharpe 0.48, 46% exposure.

Return/drawdown alternative: 볼린저 밴드 돌파 — CAGR is 26.4%p higher than buy and hold, while drawdown improves by 22.3%p (CAGR 7.1%, MDD -40.3%, exposure 4%).

The alternative must retain 75% of buy-and-hold CAGR, improve drawdown by at least 20% and 5 percentage points, and stay below 95% exposure; the ranking weights return retention 60% and drawdown improvement 40%.

Strategy · parametersCAGRMDDSharpeCalmarTotalTradesExposure
ADX / DI 방향성
period=31, threshold=9
11.3%-77.1%0.480.155.5x16546%
SMA 크로스오버
fast=42, slow=190
9.6%-68.6%0.430.144.3x1939%
MACD
fast=22, slow=45, signal=18
-17.5%-98.9%0.40-0.180.0x17151%
EMA 크로스오버
fast=34, slow=197
6.5%-74.1%0.360.092.7x1934%
볼린저 밴드 돌파
n=18, k=3.5
7.1%-40.3%0.340.183.0x164%
Donchian 채널 돌파
entryN=32, exitN=88
-17.3%-99.2%0.30-0.170.0x3368%
ROC 모멘텀
n=140, threshold=0.01
1.6%-81.1%0.300.021.3x13542%
Keltner 채널 돌파
emaPeriod=18, atrPeriod=14, mult=2.4
-4.3%-93.5%0.24-0.050.5x6115%
Parabolic SAR
step=0.025, maxStep=0.16
-23.6%-98.9%0.17-0.240.0x34747%
Supertrend
period=26, mult=2.6
-20.9%-99.4%0.13-0.210.0x14344%
Buy and hold-15.1%-99.4%0.56-0.150.1x1100%
0.01 0.1 1x 2011 2013 2015 2017 2019 2021 2023 2025 ADX / DI 방향성Buy and hold
ADX / DI 방향성: Solid strategy line versus dashed buy-and-hold line. Log scale.
0% -25% -50% -75% -99% 2011 2013 2015 2017 2019 2021 2023 2025 Buy and holdADX / DI 방향성
ADX / DI 방향성 maximum drawdown -77.1% (2024-02-27 → 2025-12-02), prior peak not yet recovered.

Rules of the top strategy

Looks at both the direction and the strength of the trend; holds only in a strong uptrend.

Method and caveats

Past performance does not guarantee future returns. Parameters were carried forward from the latest full optimization and replayed on this monthly dataset. 0.5% trading costs are included; taxes, slippage and rejected orders are not.
Re-optimize the same period and setupMore US assetsAll asset reports

Read next